582 results on '"Viapiana, O"'
Search Results
152. AB0684 Bone Metabolism in a Large Cohort of Patients with Systemic Sclerosis: Table 1
153. AB0436 Persistence of Clinical Remission by a Decreased Treatment Regimen of 4 MG/KG Intravenous Tocilizumab: A Randomized Clinical Trial
154. AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis
155. SAT0112 Cardiovascular Risk in Rheumatoid Arthritis Patients: Subclinical Left Ventricular Systolic Dysfunction in Asymptomatic Patients
156. Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
157. Risk factors for hip fracture in elderly persons
158. Physical activity and bone turnover markers: a cross-sectional and a Longitudinal study
159. Osteoporosi ed attività sportiva
160. Ruolo della vitamina D
161. Variazione della densità minerale ossea ed attività antifratturativa
162. La correzioned ell'ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica
163. La correzione dell’ipovitaminosi D nel lungo termine: confronto tra diverse modalità di somministrazione di vitamina D nella pratica clinica
164. Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of Tocilizumab in Selected Italian Rheumatology Centers
165. Vitamin D and rheumatic diseases
166. AB1090 Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of TOCILIZUMAB in Selected Italian Rheumatology Centers
167. SAT0415 Effects of Intra-Articular Clodronate in the Treatment of Knee Osteoarthritis: Results of A Double-Blind, Randomised Placebo-Controlled Trial
168. THU0357 Prednisone Compared to Methyl-Prednisolone in the Polymyalgia Rheumatica Treatment
169. IBANDRONATE: NEW OPTIONS IN THE TREATMENT OF OSTEOPOROSIS
170. Insight into the WNT system and its drug related response
171. Nuove prospettive nella patogenesi dell’artrosi
172. Osteoporosi senile: nuove acquisizioni diagnostiche e accenni terapeutici
173. Bisphosphonates vs infliximab in ankylosing spondylitis treatment
174. FRI0117 Analysis of risk for cardiovascular events and assessment of diagnostic and therapeutic management of patients with rheumatoid arthritis in clinical practice: the epidauro registry.
175. AB0514 Bisphosphonates versus infliximab in ankylosing spondylitis treatment
176. AB0528 Bone mineral density, vertebral fractures and their determinants in ankylosing spondylitis
177. FRI0116 Epidemiology and hospitalization rate of rheumatoid arthritis patients in real world setting in italy
178. AB0285 Correlation between serum levels of parathyroid hormone and DICKKOPF-1 in patients with rheumatoid arthritis
179. Duration of treatment for osteoporosis
180. I bisfosfonati e l'osteolisi paraprotesica
181. Wnt pathway in patients with primary hyperparathyroidism
182. Vitamin D and fractures: a sistematic review
183. Improvements in the management of rheumatic patients from vertebral image obtained through dual-energy X-ray absorptiometry
184. Pathophysiology of osteoarthritis: perspectives
185. How much does an antiinflammatory treatment cost?
186. Risk factors for hip fracture in elderly persons
187. The waning of teriparatide efficacy in postmenopausal osteoporosis is associated with increasing serum levels of DKK1
188. Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism
189. Risk of secondary vertebral fracture following a vertebroplasty and predisposing clinical factors
190. Soft-tissue effects on quantitative ultrasound measurements at the phalanges
191. Post-surgical management of elderly patients with hip fracture
192. Intra-articular clodronate for the treatment of knee osteoarthritis: dose ranging study vs hyaluronic acid
193. 100 Quantitative Ultrasound at the Phalanx in Patients with Anorexia Nervosa
194. Ibandronate: New option in the treatment of osteoporosis
195. PMS62 - Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of Tocilizumab in Selected Italian Rheumatology Centers
196. Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
197. Long-Term Effects of Amino-Bisphosphonates on Circulating [gamma][delta] T Cells.
198. Allergy and the bone: unexpected relationships.
199. Capacitively coupled electric field for pain relief in patients with vertebral fractures and chronic pain.
200. Bone mineral density of patients affected by clonal mast cell disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.